Of the 13 analysts actively tracking Olin (OLN) over the past three months, 61% have recommended a “buy,” while 39% have recommended a “hold.” None of the analysts have recommended a “sell.”
The analysts’ consensus puts Olin’s 12-month target price at $35.09, implying a potential return of 8.9% from its closing price of $32.23 on August 31, 2017.
Why analysts are recommending “buys” and “holds” for Olin
Although Olin reported a net loss in 2Q17, OLN reaffirmed its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) to be $1 billion for fiscal 2017. This likely influenced analysts to recommend a “buy” or a “hold” for the stock.
Suntrust Robinson has rated Olin stock a “buy” and has recommended a target price of $36, implying a return potential of 11.7% over the closing price of $32.23 on August 31, 2017.
Bank of America Merrill Lynch has also rated Olin a “buy,” with a recommended target price of $40, implying a return potential of 24.1% over the closing price of $32.23 on August 31, 2017.
Investors can indirectly hold Olin by investing in the iShares US Basic Materials ETF (IYM), which has 0.90% of its portfolio in Olin. IYM also holds Monsanto (MON), Praxair (PX), and LyondellBasell (LYB), with weights of 8.3%, 6.1%, and 4.8%, respectively, as of August 31, 2017.